Form 4: Amgen EVP Esteban Santos Reports Stock and Option Awards

EVP of Operations at Amgen, Esteban Santos, reports acquisition of stock and option awards.

Summary

• Esteban Santos, EVP of Operations at Amgen, filed a Form 4 detailing changes in beneficial ownership.
• The report indicates the acquisition of 3,327 shares of common stock and 21,510 non-qualified stock options on May 6, 2025.
• The restricted stock units (RSUs) vest in four equal annual installments starting May 6, 2026.
• Vested RSUs will be paid in shares of Amgen's common stock on a one-to-one basis.
• The non-qualified stock options also vest in four equal annual installments commencing on May 6, 2026.
• Santos also indirectly owns 882.4151 shares of common stock through the company's 401(k) plan.
• These shares include 373 Dividend Equivalents (DEs) granted pursuant to the Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.

Sentiment

Score: 6

Explanation: The document is a standard regulatory filing detailing stock and option grants. It's neutral in tone and doesn't contain any particularly positive or negative information.

Positives

• The grant of RSUs and stock options to a key executive like Esteban Santos could be seen as a positive sign, aligning his interests with the company's long-term performance.

Future Outlook

The vesting schedule of the RSUs and stock options suggests a multi-year commitment from the executive.

Industry Context

Form 4 filings are a routine part of executive compensation and provide transparency into the holdings of company insiders.

Stakeholder Impact

• The stock and option awards could incentivize the executive to improve company performance, potentially benefiting shareholders.

Key Dates

Keywords

Form 4, Amgen, AMGN, Esteban Santos, Stock Options, Restricted Stock Units, Beneficial Ownership, Equity Incentive Plan, 401(k) Plan, EVP Operations